Your browser doesn't support javascript.
loading
Molecular targeting of Bcl-2 overcomes prostate cancer cell adaptation to XIAP gene downregulation.
Nakano, Y; Bilim, V; Yuuki, K; Muto, A; Kato, T; Nagaoka, A; Tomita, Y.
Affiliation
  • Nakano Y; Department of Urology, Yamagata University School of Medicine, Yamagata, Japan.
Prostate Cancer Prostatic Dis ; 12(1): 34-40, 2009.
Article in En | MEDLINE | ID: mdl-18475287

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Prostatic Neoplasms / Drug Resistance, Neoplasm / Proto-Oncogene Proteins c-bcl-2 / X-Linked Inhibitor of Apoptosis Protein Limits: Humans / Male Language: En Journal: Prostate Cancer Prostatic Dis Year: 2009 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Prostatic Neoplasms / Drug Resistance, Neoplasm / Proto-Oncogene Proteins c-bcl-2 / X-Linked Inhibitor of Apoptosis Protein Limits: Humans / Male Language: En Journal: Prostate Cancer Prostatic Dis Year: 2009 Document type: Article